Factsheets & Guidelines

Guidelines for the Implementation of Mother-Child Units in Canadian Correctional Facilities

Developed by the CCPHE and University of British Columbia, the publication describes guiding principle

OHCHR Releases New UPR Submission Guidelines

The Office of the High Commissioner for Human Rights (OHCHR) has released new guidelines for stakeholder

FAQ: The Abortion Pill Mifegymiso

Below are some answers to frequently asked questions about Mifegymiso and medical abortion as well as a link to our Mifegymiso pocket guide.

The Politics of Mifegymiso in Canada: Key Dates and Milestones

July 2015: Health Canada approves the abortion pill Mifegymiso, the Canadian brand name for the combination of Mifepristone and Misoprostol.

Canada's Global Leadership on Sexual and Reproductive Health And Rights Within the Thrive Agenda

Canada received global praise in 2017 with a bold $650 million three-year investment in women’s sexual and reproductive health and rights (SRHR).

Free and Equal Campaign: Intersex Factsheet

Source: Free and Equal Campaign

This app features content from the Your Sexual Health Hub and is available if you are offline. To visit the full Action Canada for Sexual Health and Rights website, go to www.actioncanadashr.org.

Want to Talk to Someone?

For confidential information and referrals to sexual and reproductive health services, including abortion, call our toll-free Access Line 7 days a week between 9:00AM and 9:00PM EST. You can also text us at 613-800-6757. Learn more.

Call the Access Line
1-888-642-2725

General Inquiries

613-241-4474
info@actioncanadaSHR.org

Donor Inquiries
613-241-4474 x 10800
donate@actioncanadaSHR.org

Media Inquiries
613-241-4474 x 13200
media@actioncanadaSHR.org